Extract
SARS-CoV-2 can cause severe pneumonia requiring invasive mechanical ventilation [2], in the context of atypical acute respiratory distress syndrome (ARDS) [3]. The magnitude of the epidemic places an unprecedented pressure on intensive care units (ICU), making avoidance of intubation a critical issue.
Abstract
COVID-19 pneumonia can be life-threatening. Given the unprecedented burden place on ICU resources by the epidemic, avoiding intubation is a major issue. This study suggests that CPAP can achieve this objective.
Acknowledgements
1) the authors gratefully acknowledge the help of the following persons, listed as collaborators of the study : ARNULF Isabelle, ATTALI Valérie, BELHACHIMI Zakaria, BEURTON Alexandra, BOUZNAD Yasmine, DELEMAZURE Julie, DELERIS Robin, DODET Pauline, DRES Martin, DUGUET Alexandre, EL-KOUARI Fadwa, ESTEBAN-AMARILLA Christina, GALARZA JIMENEZ Maria Alejandra, GAZANIOL Claire, HAUDEBOURG Luc, HAZIOT Noémie, HELLY DE TAURIERS Pierre, LAVENEZIANA Pierantonio, LECRONIER Marie, LEMAREC Julien, LONDNER Cécile, MAISONOBE Jeanne, MALRIN Roxane, MAYAUX Julien, MENDOZA Alexis, MORA Pierre, MORAWIEC Elise, MOURTADA Leila, NEMLAGHI Safaa, OHAYON Raphaelle, ORCEL Brigitte, REDOLFI Stefania, RIQUIER Claire, SOYEZ Bérénice, STRAUS Christian, VIROLLE Sara, WOZNIAK Estelle.
Footnotes
Data availability: The authors will provide raw data to other researchers upon reasonable request.
Conflict of interest: Dr. Oranger has nothing to disclose.
Conflict of interest: Dr. Gonzalez-Bermejo has nothing to disclose.
Conflict of interest: Dr. Dacosta-Noble has nothing to disclose.
Conflict of interest: Dr. Llontop has nothing to disclose.
Conflict of interest: Dr. Guerder has nothing to disclose.
Conflict of interest: Dr. Trosini-Desert has nothing to disclose.
Conflict of interest: Dr. Faure has nothing to disclose.
Conflict of interest: Dr. Raux has nothing to disclose.
Conflict of interest: Dr. Decavele has nothing to disclose.
Conflict of interest: Dr. Demoule has nothing to disclose.
Conflict of interest: Dr. Morélot-Panzini reports personal fees from Astra-Zeneca, personal fees from Chiesi, personal fees from Menarini, personal fees from SOS oxygene, personal fees from ADEP, personal fees from Vivisol, personal fees from Resmed, outside the submitted work;.
Conflict of interest: Dr. Similowski reports personal fees from AstraZeneca France, personal fees from Boerhinger Ingelheim France, personal fees from GSK France, personal fees and non-financial support from Novartis France, personal fees from TEVA France, personal fees from Chiesi France, personal fees from Lungpacer Inc, personal fees from ADEP Assistance, grants from Air Liquide Medical Systems, outside the submitted work;.
- Received May 9, 2020.
- Accepted May 11, 2020.
- Copyright ©ERS 2020
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.